POZ Community Forums
Meds, Mind, Body & Benefits => Research News & Studies => Topic started by: Jmarksto on November 06, 2012, 10:12:24 am
-
Western and Sumagen to release preliminary results from HIV/AIDS vaccine trials
By Communications Staff
Monday, November 5, 2012
WHAT: Western University and Sumagen Canada will hold a briefing for media and London's research community regarding preliminary results for the first-ever human applied clinical study (SAV CT 01) of the world's only preventative HIV vaccine based on a genetically modified killed whole virus (SAV001-H), which was initiated in March 2012.
Last year, SAV001-H received approval by the United States Food and Drug Administration (FDA) to start human clinical trials.
http://communications.uwo.ca/media/hivvaccine/
WHEN: Tuesday, November 6, 2012 at 11 a.m.
WHERE: Siebens Drake Research Institute, Room 217, Western University, London, Ontario
WHO: Dr. Chil-Yong Kang of Western's Schulich School of Medicine & Dentistry and Dr. Dong Joon Kim of Sumagen Co. Ltd.
-
At this point no news means bad news?
-
Here is the link to the full story on the press release:
http://tinyurl.com/bvmu7dr
The short story is that "the initial results showed a significant increase in antibody production in participants, without causing any unusual responses to the volunteers’ immune system." and they are moving into phase 2 trials with 600 HIV negative, high risk, participants.
Another small, but important, step in the overall process.....
JM